BDBM106979 US8592454, 192

SMILES CN([C@@H]1CN(CC1c1ccc(F)cn1)C(=O)C1CCN(CC1)C(C)=O)C(=O)N(C)c1cc(cc(c1)C(F)(F)F)C(F)(F)F

InChI Key InChIKey=OIFPROSOIDRACJ-UHFFFAOYSA-N

Data  3 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 3 hits for monomerid = 106979   

TargetSubstance-P receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50: 0.0320nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetSubstance-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50: 120nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent

TargetNeuromedin-K receptor(Human)
Takeda Pharmaceutical

US Patent
LigandPNGBDBM106979(US8592454, 192)
Affinity DataIC50: 4.40E+3nMAssay Description:Radioligand receptor binding inhibitory assay using human NK receptor.More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/17/2014
Entry Details
Go to US Patent